AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34428592 — intervention group
Group type: EXPERIMENTAL
Intervention: sacubitril/valsartan
Number of subjects: 140
Study 34428592 — intervention group
Group type: COMPARATOR
Intervention: enalapril
Number of subjects: 140
Study 34251458 — intervention group
Group type: EXPERIMENTAL
Intervention: Total FORTA score ≥ 7
Number of subjects: 3239
Study 34251458 — intervention group
Group type: EXPERIMENTAL
Intervention: FORTA sub-scores for PIM use and overuse
Number of subjects: 3239
Study 34251458 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 3239
Study 34251458 — intervention group
Group type: EXPERIMENTAL
Intervention: Total FORTA and potentially inappropriate medication score
Number of subjects: 3239
Study 34251458 — intervention group
Group type: EXPERIMENTAL
Intervention: Men and rectal cancer patients
Number of subjects: 3239
Study 32007513 — intervention group
Group type: EXPERIMENTAL
Intervention: Serlopitant 5 mg daily for 8 weeks
Number of subjects: 204
Study 32007513 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study 32007513 — intervention group
Group type: EXPERIMENTAL
Intervention: Serlopitant 5 mg
Number of subjects: 204
Study 35379538 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity resistance exercise program
Number of subjects: 99
Study 35379538 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care, online education, and personalized diabetes diet intervention (Control)
Number of subjects: 99
Study 34339456 — intervention group
Group type: EXPERIMENTAL
Intervention: Short inter-pregnancy interval (<24 months)
Number of subjects: 496
Study 34339456 — intervention group
Group type: EXPERIMENTAL
Intervention: Age over 30 years at first birth
Number of subjects: 496
Study 34339456 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-use of modern contraceptive
Number of subjects: 496
Study 34339456 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of breastfeeding for less than 12 months
Number of subjects: 496
Study 34339456 — intervention group
Group type: EXPERIMENTAL
Intervention: Parity above four
Number of subjects: 496
Study 34339456 — intervention group
Group type: EXPERIMENTAL
Intervention: Unintended pregnancy
Number of subjects: 496
Study 32553790 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination postoperative radiotherapy (PORT) and androgen deprivation therapy (ADT)
Number of subjects: 502
Study 36206874 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective touch (slow/soft brushing)
Number of subjects: 122
Study 36206874 — intervention group
Group type: COMPARATOR
Intervention: Nonaffective touch (fast brushing)
Number of subjects: 122
Study 36206874 — intervention group
Group type: COMPARATOR
Intervention: No touch
Number of subjects: 122
Study 34479619 — intervention group
Group type: EXPERIMENTAL
Intervention: Anyu Peibo Capsule (1.6 g per day for 8 weeks)
Number of subjects: 0
Study 34479619 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32541288 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective labor induction at 39 weeks of gestation
Number of subjects: 1201
Study 32541288 — intervention group
Group type: COMPARATOR
Intervention: Expectant management
Number of subjects: 1201
Study 34599693 — intervention group
Group type: EXPERIMENTAL
Intervention: WBVE ? OGTT
Number of subjects: 18
Study 34599693 — intervention group
Group type: EXPERIMENTAL
Intervention: OGTT ? WBVE
Number of subjects: 18
Study 34599693 — intervention group
Group type: EXPERIMENTAL
Intervention: WBVE
Number of subjects: 18
Study 34599693 — intervention group
Group type: COMPARATOR
Intervention: OGTT-alone
Number of subjects: 18
Study 34189814 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signatures
Number of subjects: 895
Study 34189814 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiomics signature
Number of subjects: 895
Study 34189814 — intervention group
Group type: COMPARATOR
Intervention: Hematoma volume
Number of subjects: 895
Study 32182387 — intervention group
Group type: COMPARATOR
Intervention: Topical ketoconazole 2% cream twice daily and placebo (GI)
Number of subjects: 90
Study 32182387 — intervention group
Group type: COMPARATOR
Intervention: Topical 0.1% adapalene gel twice daily and placebo (GII)
Number of subjects: 90
Study 32182387 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical combination of 0.1% adapalene gel (at night) and ketoconazole 2% cream (in the morning) (GIII)
Number of subjects: 90
Study 35015037 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-weekly subcutaneous semaglutide, 2.4 mg
Number of subjects: 338
Study 35015037 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily subcutaneous liraglutide, 3.0 mg
Number of subjects: 338
Study 35015037 — intervention group
Group type: COMPARATOR
Intervention: Pooled placebo
Number of subjects: 338
Study 32081690 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser-assisted blepharoplasty (initial incision with CO2 laser at 3 W, remaining steps at 9 W)
Number of subjects: 21
Study 32081690 — intervention group
Group type: COMPARATOR
Intervention: Scalpel-assisted blepharoplasty (initial incision with scalpel, remaining steps with CO2 laser at 9 W)
Number of subjects: 21
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiparasitic treatment (specifics not provided)
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysts larger than 14 mm
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Cysts with edema at baseline
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: More than 24 months with seizures
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild antibody response
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased dose albendazole regime
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower doses of dexamethasone
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Not receiving early antiparasitic retreatment
Number of subjects: 220
Study 32556276 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete cure
Number of subjects: 220
Study 36443792 — intervention group
Group type: EXPERIMENTAL
Intervention: P-ETP (plasma endotrophin)
Number of subjects: 3531
Study 36443792 — intervention group
Group type: EXPERIMENTAL
Intervention: U-ETP (urine endotrophin)
Number of subjects: 3531
Study 36443792 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin treatment
Number of subjects: 3531
Study 34160288 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 IU·kg body wt-1 rHuEPO injections every second day for 3 weeks at sea level
Number of subjects: 39
Study 34160288 — intervention group
Group type: EXPERIMENTAL
Intervention: Altitude exposure (2,320 m)
Number of subjects: 39
Study 34160288 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent rHuEPO treatment and altitude exposure
Number of subjects: 39
Study 34160288 — intervention group
Group type: COMPARATOR
Intervention: Altitude exposure alone
Number of subjects: 39
Study 33210604 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium supplementation (300 mg)
Number of subjects: 264
Study 33210604 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium-vitamin B6 supplementation (300 mg magnesium + 30 mg vitamin B6)
Number of subjects: 264
Study 33210604 — intervention group
Group type: COMPARATOR
Intervention: Magnesium alone
Number of subjects: 264
Study 34755426 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone treatment
Number of subjects: 1767
Study 34755426 — intervention group
Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 1767
Study 33880781 — intervention group
Group type: EXPERIMENTAL
Intervention: Semiparametric proportional rate function models
Number of subjects: 0
Study 33880781 — intervention group
Group type: EXPERIMENTAL
Intervention: Cox regression
Number of subjects: 0
Study 33880781 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent event analyses
Number of subjects: 0
Study 33880781 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-to-first-event analyses
Number of subjects: 0
Study 36242622 — intervention group
Group type: EXPERIMENTAL
Intervention: Biodegradable hyaluronic acid microneedle patch (BHMN patch)
Number of subjects: 15
Study 36242622 — intervention group
Group type: COMPARATOR
Intervention: Needleless patch (NL patch)
Number of subjects: 15
Study 36242622 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (BHMN patch and NL patch)
Number of subjects: 15
Study 33397869 — intervention group
Group type: EXPERIMENTAL
Intervention: Mitral valve replacement with preservation of mitral subvalvular apparatus (Group A)
Number of subjects: 60
Study 33397869 — intervention group
Group type: COMPARATOR
Intervention: Conventional mitral valve replacement (Group B)
Number of subjects: 60
Study 32658775 — intervention group
Group type: EXPERIMENTAL
Intervention: One-class support vector machine (OCSVM) for evaluating mental workload during driving tasks
Number of subjects: 12
Study 32658775 — intervention group
Group type: COMPARATOR
Intervention: N-back task with five difficulty levels (none to 3-back)
Number of subjects: 12
Study 32658775 — intervention group
Group type: COMPARATOR
Intervention: Driving simulator (DS)
Number of subjects: 12
Study 35700203 — intervention group
Group type: EXPERIMENTAL
Intervention: Jholmal (locally prepared bio-fertilizer and pesticides)
Number of subjects: 0
Study 35700203 — intervention group
Group type: EXPERIMENTAL
Intervention: Straw mulching
Number of subjects: 0
Study 35700203 — intervention group
Group type: COMPARATOR
Intervention: Farmer's business usual practice (control for jholmal)
Number of subjects: 0
Study 35700203 — intervention group
Group type: COMPARATOR
Intervention: Non-mulched trials (control for straw mulching)
Number of subjects: 0
Study 34217127 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy with 3% lavender oil (2.5 cc, gentle massage for 10 min every night for a month)
Number of subjects: 75
Study 34217127 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 26)
Number of subjects: 75
Study 34217127 — intervention group
Group type: COMPARATOR
Intervention: Control (n = 26)
Number of subjects: 75
Study 33909914 — intervention group
Group type: EXPERIMENTAL
Intervention: RSD with perioscope
Number of subjects: 38
Study 34492725 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized homeopathic medicines (IHMs)
Number of subjects: 75
Study 34492725 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 36473040 — intervention group
Group type: COMPARATOR
Intervention: Opioid anesthesia (Fentanyl group - FG)
Number of subjects: 80
Study 36473040 — intervention group
Group type: EXPERIMENTAL
Intervention: Opioid free anesthesia (Opioid Free Anesthesia Group - OFAG)
Number of subjects: 80
Study 33412107 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite type‐2 biomarker strategy
Number of subjects: 0
Study 33412107 — intervention group
Group type: COMPARATOR
Intervention: Symptom–risk‐based algorithm
Number of subjects: 0
Study 32133910 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 mg nicotine patch
Number of subjects: 38
Study 32133910 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of L-tyrosine
Number of subjects: 38
Study 32133910 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33843562 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent, kindergarten-based, family-involved intervention
Number of subjects: 6268
Study 33843562 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental characteristics (underestimation of children's weight status, parental overweight, mothers' pre-pregnancy overweight/obesity)
Number of subjects: 6268
Study 34580104 — intervention group
Group type: EXPERIMENTAL
Intervention: Informed consent procedures in cluster randomised trials (CRTs)
Number of subjects: 0
Study 34580104 — intervention group
Group type: EXPERIMENTAL
Intervention: Framework for informed consent in CRTs
Number of subjects: 0
Study 34580104 — intervention group
Group type: EXPERIMENTAL
Intervention: Examples of CRTs
Number of subjects: 0
Study 35500883 — intervention group
Group type: EXPERIMENTAL
Intervention: NIV-NAVA
Number of subjects: 20
Study 35500883 — intervention group
Group type: COMPARATOR
Intervention: NCPAP
Number of subjects: 20
Study 33870956 — intervention group
Group type: EXPERIMENTAL
Intervention: Personal motivation calls
Number of subjects: 260
Study 33870956 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated motivational calls
Number of subjects: 260
Study 33870956 — intervention group
Group type: COMPARATOR
Intervention: No calls
Number of subjects: 260
Study 33870956 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-efficacy change at 24 weeks
Number of subjects: 260
Study 33870956 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological outcome realizations at 24 weeks
Number of subjects: 260
Study 33880691 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas preventive intervention
Number of subjects: 746
Study 35094123 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercise training (IET)
Number of subjects: 24
Study 35094123 — intervention group
Group type: COMPARATOR
Intervention: Control period
Number of subjects: 24
Study 36205998 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplant
Number of subjects: 4445
Study 36205998 — intervention group
Group type: COMPARATOR
Intervention: Continued dialysis
Number of subjects: 4445
Study 33917668 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-competition massage on one leg (experimental)
Number of subjects: 30
Study 33917668 — intervention group
Group type: COMPARATOR
Intervention: No intervention on the opposite leg (control)
Number of subjects: 30
Study 32143877 — intervention group
Group type: EXPERIMENTAL
Intervention: Threshold inspiratory muscle training (TIMT) at 30% of maximal inspiratory pressure (MIP) for 15 min, twice per day for 8 weeks
Number of subjects: 30
Study 32143877 — intervention group
Group type: COMPARATOR
Intervention: Sham group performing at lowest pressure without change in threshold pressure
Number of subjects: 30
Study 34768288 — intervention group
Group type: EXPERIMENTAL
Intervention: Disposable endoscope
Number of subjects: 144
Study 34768288 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscope
Number of subjects: 144
Study 34219267 — intervention group
Group type: EXPERIMENTAL
Intervention: Quercetin (50 μM)
Number of subjects: 25
Study 34219267 — intervention group
Group type: COMPARATOR
Intervention: Control (frozen-thawed semen without Quercetin)
Number of subjects: 25
Study 36013125 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid Maxillary Expansion (RME) using a Hyrax type expander
Number of subjects: 32
Study 36013125 — intervention group
Group type: COMPARATOR
Intervention: Slow Maxillary Expansion (SME) using a Leaf Expander (LE)
Number of subjects: 32
Study 33875284 — intervention group
Group type: EXPERIMENTAL
Intervention: Total parietal peritonectomy (TPP) during interval cytoreductive surgery (CRS)
Number of subjects: 70
Study 35775453 — intervention group
Group type: EXPERIMENTAL
Intervention: Hybrid closed-loop (HCL) therapy
Number of subjects: 0
Study 35775453 — intervention group
Group type: COMPARATOR
Intervention: Current care
Number of subjects: 0
Study 32126031 — intervention group
Group type: EXPERIMENTAL
Intervention: Symfony extended depth-of-focus IOL
Number of subjects: 30
Study 32126031 — intervention group
Group type: COMPARATOR
Intervention: AT LISA tri 839MP IOL
Number of subjects: 30
Study 33971132 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 320
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Shovel beak extending 0-1 mm (SB0-1)
Number of subjects: 80
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Shovel beak extending 1-2 mm (SB1-2)
Number of subjects: 80
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Shovel beak extending 2-3 mm (SB2-3)
Number of subjects: 80
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Shovel beak extending 3-4 mm (SB3-4)
Number of subjects: 80
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Shovel beak extending >4 mm (SB > 4)
Number of subjects: 80
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Cracks (Cr)
Number of subjects: 80
Study 32115027 — intervention group
Group type: EXPERIMENTAL
Intervention: Bubbles (B)
Number of subjects: 80
Study 32115027 — intervention group
Group type: COMPARATOR
Intervention: Flush beak (control)
Number of subjects: 80
Study 33516964 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMath app-based HRV biofeedback
Number of subjects: 52
Study 33516964 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 52
Study 32086111 — intervention group
Group type: EXPERIMENTAL
Intervention: Low FODMAP diet
Number of subjects: 66
Study 32086111 — intervention group
Group type: COMPARATOR
Intervention: Traditional IBS diet
Number of subjects: 66
Study 33860484 — intervention group
Group type: EXPERIMENTAL
Intervention: Early double-guidewire (EDG) technique
Number of subjects: 142
Study 33860484 — intervention group
Group type: COMPARATOR
Intervention: Repeated single-guidewire (RSG) technique
Number of subjects: 142
Study 33860484 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall
Number of subjects: 142
Study 34418898 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined training (CT)
Number of subjects: 23
Study 34418898 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 23
Study 32437507 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab 3 mg/kg every 2 weeks until disease progression, unacceptable toxic effects, or death
Number of subjects: 369
Study 32437507 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab 10 mg/kg every 2 weeks until disease progression, unacceptable toxic effects, or death
Number of subjects: 369
Study 35170493 — intervention group
Group type: EXPERIMENTAL
Intervention: Anakinra
Number of subjects: 139
Study 33846727 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 100% of the estimated rumen‐degradable protein requirement (F) provided daily (D)
Number of subjects: 7
Study 33846727 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 50% of the estimated rumen‐degradable protein requirement (H) provided daily (D)
Number of subjects: 7
Study 33846727 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 100% (F) or 50% (H) provided once every 5 days (5D)
Number of subjects: 7
Study 33846727 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplemental soybean meal at 100% (F) or 50% (H) provided once every 10 days (10D)
Number of subjects: 7
Study 33846727 — intervention group
Group type: COMPARATOR
Intervention: Control group (non‐supplemented)
Number of subjects: 7
Study 33846727 — intervention group
Group type: EXPERIMENTAL
Intervention: All supplements provided
Number of subjects: 7
Study 35274585 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring (HM) of symptoms measured by the Cystic Fibrosis Respiratory Symptom Diary – Chronic Respiratory Infection Symptom Score (CFRSD‐CRISS) and forced expiratory volume in one second (FEV1)
Number of subjects: 88
Study 35274585 — intervention group
Group type: EXPERIMENTAL
Intervention: Home monitoring (HM)
Number of subjects: 88
Study 35274585 — intervention group
Group type: COMPARATOR
Intervention: Routine clinical care (RC)
Number of subjects: 88
Study 32854869 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic treatment of SCD
Number of subjects: 0
Study 32854869 — intervention group
Group type: EXPERIMENTAL
Intervention: Malocclusion
Number of subjects: 0
Study 32854869 — intervention group
Group type: EXPERIMENTAL
Intervention: Unusual orofacial findings
Number of subjects: 0
Study 32854869 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin, vaccines, and hydroxyurea
Number of subjects: 0
Study 32854869 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive oral health care
Number of subjects: 0
Study 34993933 — intervention group
Group type: EXPERIMENTAL
Intervention: Eflapegrastim (1.1, 3.3, 10, 45, 135, and 270 μg/kg)
Number of subjects: 84
Study 34993933 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim (6 mg)
Number of subjects: 84
Study 34993933 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study 33764609 — intervention group
Group type: EXPERIMENTAL
Intervention: NaOCl + EDTA + PIPS (EDTA)
Number of subjects: 144
Study 33764609 — intervention group
Group type: COMPARATOR
Intervention: NaOCl + EDTA + PIPS (distilled water)
Number of subjects: 144
Study 33764609 — intervention group
Group type: COMPARATOR
Intervention: NaOCl + PIPS (EDTA)
Number of subjects: 144
Study 33764609 — intervention group
Group type: COMPARATOR
Intervention: NaOCl + PIPS (distilled water)
Number of subjects: 144
Study 33764609 — intervention group
Group type: COMPARATOR
Intervention: NaOCl + EDTA
Number of subjects: 144
Study 33764609 — intervention group
Group type: COMPARATOR
Intervention: NaOCl
Number of subjects: 144
Study 32702567 — intervention group
Group type: EXPERIMENTAL
Intervention: Corrected nose-earlobe-xiphoid distance formula
Number of subjects: 218
Study 35664355 — intervention group
Group type: EXPERIMENTAL
Intervention: GAD-alum treatment
Number of subjects: 26
Study 34171973 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 70 mg
Number of subjects: 900
Study 34171973 — intervention group
Group type: EXPERIMENTAL
Intervention: Erenumab 140 mg
Number of subjects: 900
Study 34171973 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 900
Study 32756094 — intervention group
Group type: EXPERIMENTAL
Intervention: Pureed rice with gelling agent
Number of subjects: 62
Study 32756094 — intervention group
Group type: COMPARATOR
Intervention: Pureed rice without gelling agent
Number of subjects: 62
Study 32756094 — intervention group
Group type: EXPERIMENTAL
Intervention: Older patients (irrespective of gelling agent presence)
Number of subjects: 62
Study 35346925 — intervention group
Group type: EXPERIMENTAL
Intervention: Viewing quality measures with peer comparisons before choosing certification activities (intervention group)
Number of subjects: 254
Study 35346925 — intervention group
Group type: COMPARATOR
Intervention: Standard selection of certification activities without prior viewing of quality measures (control group)
Number of subjects: 254
Study 34396066 — intervention group
Group type: EXPERIMENTAL
Intervention: 3MTM CobanTM 2 layer system bandaging
Number of subjects: 60
Study 34396066 — intervention group
Group type: COMPARATOR
Intervention: Conventional multi-layer short-stretch bandaging
Number of subjects: 60